Medtronic Inc. (MDT): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Medtronic ( MDT) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 1.6%. By the end of trading, Medtronic fell $0.87 (-1.6%) to $54.33 on average volume. Throughout the day, 4,453,665 shares of Medtronic exchanged hands as compared to its average daily volume of 5,341,800 shares. The stock ranged in price between $54.08-$54.95 after having opened the day at $54.79 as compared to the previous trading day's close of $55.20. Other companies within the Health Services industry that declined today were: Pingtan Marine Enterprise ( PME), down 82.5%, Alliance HealthCare Services ( AIQ), down 11.1%, Utah Medical Products ( UTMD), down 9.6% and USMD Holdings ( USMD), down 8.7%.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $55.3 billion and is part of the health care sector. Shares are up 34.6% year to date as of the close of trading on Wednesday. Currently there are 7 analysts that rate Medtronic a buy, no analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, attractive valuation levels and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the positive front, Biolase ( BIOL), up 55.0%, Concord Medical Services Holdings ( CCM), up 14.8%, Dehaier Medical Systems ( DHRM), up 12.8% and CAS Medical Systems ( CASM), up 11.1%.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Medtronic Looks Vulnerable to a Bigger Decline

FDA Approves Abbott Heart Device, Stock Rises

Measure the Meaning of This Rally: Cramer's 'Mad Money' Recap (Tues 8/22/17)

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

Cramer: This Rally Isn't Without Meaning